NDC 0025-2924
CALAN SR
Verapamil Hydrochloride
CALAN SR is a Oral Tablet, Film Coated, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is Verapamil Hydrochloride.
| Product ID | 0025-2924_227045f0-f2ba-4033-ac3a-613e2e580c49 |
| NDC | 0025-2924 |
| Product Type | Human Prescription Drug |
| Proprietary Name | CALAN SR |
| Generic Name | Verapamil Hydrochloride |
| Dosage Form | Tablet, Film Coated, Extended Release |
| Route of Administration | ORAL |
| Marketing Start Date | 2021-06-01 |
| Marketing Category | NDA / |
| Application Number | NDA019152 |
| Labeler Name | Pfizer Laboratories Div Pfizer Inc |
| Substance Name | VERAPAMIL HYDROCHLORIDE |
| Active Ingredient Strength | 240 mg/1 |
| Pharm Classes | P-Glycoprotein Inhibitors [MoA],Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |